Back to GOLDMAN SACHS GROUP INC GOLDMAN SACHS GROUP INC

INMBINMB
Showing 8 of 10 quarters

Position history for GOLDMAN SACHS GROUP INCGOLDMAN SACHS GROUP INC's holdings in INMUNE BIO INC

GOLDMAN SACHS GROUP INC holds 185,245 shares of INMB (INMUNE BIO INC), worth $301,949 as of 2026-Q2. The position was decreased (-20.0% shares).

Current Value

$301,949

Current Shares

185,245

Total Value Change

+$124,030

Total Shares Change

+152,236

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
185,245
-20.0%
$301,9490.0%$1.63
0
2026-Q1
Increased
231,586
+310.1%
$261,6920.0%$1.13
25
2025-Q4
Increased
56,477
+269.0%
$88,1040.0%$1.56
24
2025-Q3
Decreased
15,304
-35.1%
$31,6790.0%$2.07
0
2025-Q2
Decreased
23,598
-42.0%
$54,5110.0%$2.31
0
2025-Q1
Decreased
40,716
-36.0%
$317,9920.0%$7.81
0
2024-Q4
Increased
63,615
+92.7%
$297,0820.0%$4.67
25
2024-Q3
Increased
33,009
+183.2%
$177,9190.0%$5.39
25

Other major holders of INMB: BlackRock, Inc., BlackRock Finance, Inc., VANGUARD GROUP INC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used